Simulations Plus to Participate in Upcoming Healthcare Conferences
February 06 2024 - 8:30AM
Business Wire
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of
modeling and simulation software and services for pharmaceutical
safety and efficacy, today announced that it will participate in
two healthcare conferences in February.
The Company will be presenting at Oppenheimer’s 34th Annual
Healthcare Life Sciences Conference taking place virtually from
February 13-14, 2024. Shawn O’Connor, chief executive officer, will
be presenting on Tuesday, February 13, 2024, at 11:20 a.m. Eastern
Time, and he will be meeting with investors throughout both days.
The live webcast of the Company’s presentation can be accessed via
this link and also on the Investors page of the Simulations Plus
website where it will be available for replay following the event.
For more information about the Oppenheimer Annual Healthcare
Conference, or to register to attend, please visit the conference
website.
The Company is also scheduled to host investor meetings at BTIG
at Snowbird – BTIG’s 11th Annual MedTech, Digital Health, Life
Science & Diagnostic Tools Conference taking place at the Cliff
Lodge in Snowbird, Utah. CEO Shawn O’Connor will be meeting
one-on-one with institutional investors on Tuesday and Wednesday,
February 13-14, 2024. The Company’s slide presentation will be
available on the Investors page of the Simulations Plus website.
For more information about the BTIG conference, please visit the
BTIG website.
About Simulations Plus, Inc.
Serving clients worldwide for more than 25 years, Simulations
Plus is a leading provider in the biosimulation market providing
software and consulting services supporting drug discovery,
development, research, and regulatory submissions. We offer
solutions that bridge artificial intelligence (AI)/machine
learning, physiologically based pharmacokinetics, quantitative
systems pharmacology/toxicology, and population PK/PD modeling
approaches. Our technology is licensed and applied by major
pharmaceutical, biotechnology, and regulatory agencies worldwide.
For more information, visit our website at
www.simulations-plus.com. Follow us on LinkedIn | Twitter |
YouTube.
Environmental, Social, and Governance (ESG)
We focus our Environmental, Social, and Governance (ESG) efforts
where we can have the most positive impact. To learn more about our
latest initiatives and priorities, please visit our website to read
our 2022 ESG update.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240206247332/en/
Simulations Plus Investor Relations
Renee Bouche 661-723-7723 renee.bouche@simulations-plus.com
Financial Profiles Lisa Fortuna
310-622-8251 slp@finprofiles.com
Simulations Plus (NASDAQ:SLP)
Historical Stock Chart
From Sep 2024 to Oct 2024
Simulations Plus (NASDAQ:SLP)
Historical Stock Chart
From Oct 2023 to Oct 2024